Home›Search›Безопасность и риск фармакотерапии

Безопасность и риск фармакотерапии

Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» · Russian Federation · Est. 2014

ISSN2312-7821eISSN2619-1164

SJR Q4✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ DOAJ-listed52

✓ Corroboration (1 more)+6

Total58

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.135

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

356

Total Citationsi

733

2yr Mean Citednessi

0.64

Open Impact Factor alternative

Aims & Scope✦ Inferred from recent articles

The journal focuses on the safety and efficacy of pharmacotherapy, including the assessment of adverse drug reactions, pharmacogenetics, and the development of personalized treatment strategies. It also covers pharmacovigilance systems, drug development, and regulatory aspects of medicinal products, with a particular emphasis on the Russian Federation.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionRussian Federation

Primary LanguageRussian

1st Year Published2014

Annual Volume~ 42 articles / year

StatusActive (last: 2025)

Total Publications356

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/12 · 67%

✅

Do you know the journal / publisher?

Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2312-7821 / 2619-1164

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

Russian

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

124

2019

330

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health Professions (miscellaneous)Q4

Pharmacology (nursing)Q4

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4

PharmacyQ4

Subject Classification

Research Topics (OpenAlex)

Pharmacovigilance and Adverse Drug ReactionsComputational Drug Discovery MethodsLegal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesPharmaceutical studies and practicesPharmaceutical Economics and PolicyDrug-Induced Hepatotoxicity and ProtectionDrug-Induced Adverse ReactionsAcademic Publishing and Open Access

Frequently asked questions about Безопасность и риск фармакотерапии

Is Безопасность и риск фармакотерапии a predatory journal?

PubScope has no integrity flags on record for Безопасность и риск фармакотерапии: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 58/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Безопасность и риск фармакотерапии?

Безопасность и риск фармакотерапии is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.135.

Is Безопасность и риск фармакотерапии indexed in Scopus and Web of Science?

Безопасность и риск фармакотерапии is indexed in Scopus, DOAJ.